Angell, C.D.; Lapurga, G.; Sun, S.H.; Johnson, C.; Savardekar, H.; Rampersaud, I.V.; Fletcher, C.; Albertson, D.; Ren, C.; Suarez-Kelly, L.P.;
et al. Targeting Myeloid-Derived Suppressor Cells via Dual-Antibody Fluorescent Nanodiamond Conjugate. Nanomaterials 2024, 14, 1509.
https://doi.org/10.3390/nano14181509
AMA Style
Angell CD, Lapurga G, Sun SH, Johnson C, Savardekar H, Rampersaud IV, Fletcher C, Albertson D, Ren C, Suarez-Kelly LP,
et al. Targeting Myeloid-Derived Suppressor Cells via Dual-Antibody Fluorescent Nanodiamond Conjugate. Nanomaterials. 2024; 14(18):1509.
https://doi.org/10.3390/nano14181509
Chicago/Turabian Style
Angell, Colin D., Gabriella Lapurga, Steven H. Sun, Courtney Johnson, Himanshu Savardekar, Isaac V. Rampersaud, Charles Fletcher, David Albertson, Casey Ren, Lorena P. Suarez-Kelly,
and et al. 2024. "Targeting Myeloid-Derived Suppressor Cells via Dual-Antibody Fluorescent Nanodiamond Conjugate" Nanomaterials 14, no. 18: 1509.
https://doi.org/10.3390/nano14181509
APA Style
Angell, C. D., Lapurga, G., Sun, S. H., Johnson, C., Savardekar, H., Rampersaud, I. V., Fletcher, C., Albertson, D., Ren, C., Suarez-Kelly, L. P., Rampersaud, A. A., & Carson, W. E., III.
(2024). Targeting Myeloid-Derived Suppressor Cells via Dual-Antibody Fluorescent Nanodiamond Conjugate. Nanomaterials, 14(18), 1509.
https://doi.org/10.3390/nano14181509
